Bob Martin Easy To Use Dewormer Granules For Dogs 888.8 Mg
Revised: May 2015
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Easy to Use Dewormer Granules for Dogs 888.8mg
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 4g sachet contains:
Active Substance(s) mg
For a full list of excipients see section 6.1.
3. PHARMACEUTICAL FORM
White to off-white, free flowing, coarse granules.
4. CLINICAL PARTICULARS
4.1 Target species
4.2 Indications for use, specifying the target species
Bob Martin Easy to Use Dewormer Granules for Dogs is indicated for the treatment of common gastro-intestinal roundworms that can infect dogs.
also has an ovicidal effect on nematode eggs.
hypersensitivity to active substance.
warnings for each target species
Do not administer if your dog is sick or recovering from an illness.
4.5 Special precautions for use
for use in animals
precautions to be taken by the person administering the veterinary
medicinal product to animals
Direct contact with the skin should be kept to a minimum. Avoid inhalation of granule dust. Wash hands after use.
4.6 Adverse reactions (frequency and seriousness)
4.7 Use during pregnancy, lactation or lay
Not recommended for the treatment of pregnant bitches.
Nursing bitches should be treated at the same time as their puppies.
4.8 Interaction with other medicinal products and other forms of Interaction
4.9 Amounts to be administered and administration route
For oral administration only, sprinkled onto food.
For the routine treatment of adult dogs a dosage of 100mg fenbendazole/kg is recommended.
Administer 4g of ‘Bob Martin Easy to Use Dewormer Granules for Dogs 888.8mg’ per 8.8kg (19lb 4oz) bodyweight as a single dose. This is equivalent to Fenbendazole 100mg/kg. The dose should be administered by mixing the granules with approximately one third of the dog’s usual ration. Once the dog has eaten this portion, the remainder of the food may be given.
For the treatment of clinical worm infestation in adult dogs, administer 4g of ‘Bob Martin Easy to Use Dewormer Granules for Dogs 888.8mg’ per 17.6kg (38lb 8oz) bodyweight daily for 3 days. This is equivalent to Fenbendazole 51mg/kg. The dose should be administered by mixing the granules with approximately one third of the dog’s usual ration. Once the dog has eaten this portion, the remainder of the food may be given.
In households owning more than one dog, give the granules to each dog individually, ensuring that other dogs do not have access to the treated food during the period of the dose being administered.
4.10 Overdose (symptoms, emergency procedures, and antidotes) if necessary
Benzimidazoles have a wide safety margin.
5. PHARMACOLOGICAL PROPERTIES
Anthelmintics, Benzimidazoles and related substances
ATCVet code: QP52AC13
5.1 Pharmacodynamic properties
Bob Martin Easy to Use Dewormer Granules for Dogs contains fenbendazole which is a member of the benzimidazole family of anthelmintics and has been in veterinary use for a number of years. Fenbendazole acts against helminths by disrupting the formulation of microtubules by binding to tubulin in parasitic intestinal cells hence preventing the absorption of glucose; parasites are gradually starved to death. Fenbendazole displays preference for helminth as opposed to mammalian tubulin; this appears to be due to the fact that the formation of the parasitic tubulin-fenbendazole complex is more favourable kinetically under physiological conditions than for the mammalian tubulin-fenbendazole complex.
No specific pharmacokinetic studies have been performed with the product.
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Sodium lauryl sulphate.
Shelf life of the veterinary medicinal product as packaged for sale: 3 years.
6.4 Special precautions for storage
i) Store in dry place.
ii) Discard any remaining medicated feed.
6.5 Nature and composition of immediate packaging
Foil paper sachets containing 4g of granules. Each carton contains 4 x 4g sachets.
6.6 Special precautions for the disposal of unused veterinary medicinal products or waste materials derived from the use of such products, if appropriate
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
7. MARKETING AUTHORISATION HOLDER
Chanelle Pharmaceuticals Manufacturing Ltd
8. MARKETING AUTHORISATION NUMBER
9. DATE OF THE FIRST AUTHORISATION
Date:5 February 1999
10. DATE OF REVISION OF THE TEXT
Approved: 20 May 2015
Page 4 of 4